According to our present knowledge of the physiological regulation of renin secretion (Davies and Freeman, 1976) , digitalis glycosides may influence plasma renin activity (PRA) by several mechanisms. They inhibit ion transport, they induce significant hemodynamic effects and they exert also, at least at myocardial level, an antiadrenergic activity (Mendez et aL, 1961) . In their recent study, Blaine and Zimmerman (1978) focused attention mainly on the hemodynamic and ionic effects of ouabain. Their findings, however, could assume a still greater interest when evaluated in connection with results of other investigations based on different approaches to the problem. We are studying the effects of digoxin in man under various experimental conditions in order to evaluate the importance of the ionic mechanisms and the role of an eventual antiadrenergic activity at the level of juxtaglomerular apparatus. The investigations have been done with three groups of mildly hypertensive patients. The groups were treated, respectively, with digoxin, with furosemide plus digoxin, and with furosemide plus digoxin after a prolonged treatment with oxprenoloL
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Effects of Digoxin and Digoxin Plus Furosemide on Plasma Renin Activity of Hypertensive Patients
According to our present knowledge of the physiological regulation of renin secretion (Davies and Freeman, 1976) , digitalis glycosides may influence plasma renin activity (PRA) by several mechanisms. They inhibit ion transport, they induce significant hemodynamic effects and they exert also, at least at myocardial level, an antiadrenergic activity (Mendez et aL, 1961) . In their recent study, Blaine and Zimmerman (1978) focused attention mainly on the hemodynamic and ionic effects of ouabain. Their findings, however, could assume a still greater interest when evaluated in connection with results of other investigations based on different approaches to the problem. We are studying the effects of digoxin in man under various experimental conditions in order to evaluate the importance of the ionic mechanisms and the role of an eventual antiadrenergic activity at the level of juxtaglomerular apparatus. The investigations have been done with three groups of mildly hypertensive patients. The groups were treated, respectively, with digoxin, with furosemide plus digoxin, and with furosemide plus digoxin after a prolonged treatment with oxprenoloL
The results can be summarized as follows: (1) Digoxin (0.5 mg, iv) induces a sharp and significant decrease of PRA which lasts about 3 hours (Antonello et al., 1976) . (2) The increase of PRA induced by furosemide (40 mg, per os) is greatly reduced by the subsequent administration of digoxin (0.5 mg, in gelatin capsules). This effect of digoxin develops very soon, when plasma levels of the glycoside are still low (0.2-0.4 ng/ml) and is presumably related to the concentration of the glycoside in the tubular fluid.
(3) In subjects pretreated for several days with a beta-blocker (oxprenolol, 40 mg, three times a day, per os), the effects of furosemide on PRA were reduced but digoxin was ineffective in preventing the residual response to furosemide (Dr. D. Montanaro, personal communication).
In agreement with the experimental findings of Blaine and Zimmerman, our investigations show that digitalis glycosides prevent the increase of PRA by furosemide. However, the results of the trials performed on subjects pretreated with oxprenolol suggest that an antiadrenergic activity of digoxin should play an essential role in the mechanism whereby the glycoside counteracts the increase of PRA by furosemide. 
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